sábado, 1 de diciembre de 2018

What CDC is Doing: Antibiotic Resistance (AR) Solutions Initiative | Antibiotic/Antimicrobial Resistance | CDC

What CDC is Doing: Antibiotic Resistance (AR) Solutions Initiative | Antibiotic/Antimicrobial Resistance | CDC

About the Antibiotic Resistance Solutions Initiative



CDC Funds Innovative Research to Combat Antibiotic Resistance
CDC Awards More Institutions than Ever Before to Explore Knowledge Gaps Using a One Health Approach
CDC awarded more than $15 million to 41 private and academic investigators to pilot innovative solutions to protect people from antibiotic resistance. The awards are among the most diverse the agency has ever awarded and span the One Health continuum, covering topics that relate to humans, animals, and the environment.
For the third year in a row, CDC is collaborating with researchers domestically and internationally to better understand antibiotic resistance. Antibiotic resistance causes deadly infections in humans and animals, threatens every country, and jeopardizes modern healthcare, veterinary, and agriculture industries.
For example, CDC and investigators will:
  • Analyze antibiotic-resistant germs and genes in water systems and the environment, and their contribution to human infections
  • Develop and analyze new diagnostic, sequencing, and metagenomics tools for antibiotic resistance detection and improved antibiotic use
  • Study domestic and international transmission, colonization, and prevention of antibiotic-resistant germs
  • Investigate the human microbiome and how it relates to antibiotic resistance
  • Improve antibiotic stewardship
Insights gained will inform CDC’s efforts to protect people. These pilot projects will help better detect antibiotic resistance, help advise treatment and prevention recommendations, and prevent the spread of antibiotic-resistant infections.
These awards, made through a broad agency announcement (BAA), are part of the Antibiotic Resistance Solutions Initiative and are intended to grow the agency’s innovative approaches to combat antibiotic resistance. In fiscal years 2016-2018, CDC’s Antibiotic Resistance Solutions Initiative awarded more than $39 million to BAA awardees to fight antibiotic resistance.
Learn more about: 
This year’s BAA awardees include:
  • California Department Of Public Health
  • Cleveland VA Medical Center
  • Duke University
  • Henry Ford Health System
  • ImpeDx Diagnostics Inc.
  • Iowa State University
  • Johns Hopkins Bayview Medical Center
  • Johns Hopkins University
  • Massachusetts Department of Public Health
  • Northwestern University
  • Rush University Medical Center
  • Signature Science
  • Stanford University
  • Texas Tech University
  • The Children’s Hospital of Philadelphia
  • The Ohio State University
  • Universidad del Desarrollo
  • University of Alabama at Birmingham
  • University of Arizona
  • University of California Irvine
  • University of Chicago
  • University of Georgia
  • University of Leeds
  • University of Maryland, Baltimore
  • University of Michigan
  • University of Nebraska
  • University of Oxford
  • University of Pennsylvania
  • University of South Carolina
  • University of Virginia
  • Virginia Tech
  • Washington University in St. Louis

No hay comentarios:

Publicar un comentario